Office Action Predictor
Last updated: April 15, 2026
Application No. 18/041,016

METAL-LIGAND COMPLEX, CATALYST COMPOSITION FOR PREPARING ETHYLENE-BASED POLYMER CONTAINING THE SAME, AND PREPARATION METHOD OF ETHYLENE -BASED POLYMER USING THE SAME

Non-Final OA §112
Filed
Feb 08, 2023
Examiner
PAGANO, ALEXANDER R
Art Unit
1692
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Sabic Sk Nexlene Company Pte. LTD.
OA Round
1 (Non-Final)
79%
Grant Probability
Favorable
1-2
OA Rounds
2y 1m
To Grant
83%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allow Rate
828 granted / 1049 resolved
+18.9% vs TC avg
Minimal +4% lift
Without
With
+4.1%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
65 currently pending
Career history
1114
Total Applications
across all art units

Statute-Specific Performance

§101
2.4%
-37.6% vs TC avg
§103
27.3%
-12.7% vs TC avg
§102
32.6%
-7.4% vs TC avg
§112
19.6%
-20.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1049 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claims 1-12 of D. Shin et al., US 18/041,016 (Dec. 13, 2021) are pending and under examination. Claims 1-9, 11 and 12 are in condition for allowance. Claim 10 is rejected. Rejections 35 U.S.C. 112(b) The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION. — The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Pursuant to 35 U.S.C. 112, the claim must apprise one of ordinary skill in the art of its scope so as to provide clear warning to others as to what constitutes infringement. MPEP 2173.02(II); Solomon v. Kimberly-Clark Corp., 216 F.3d 1372, 1379, 55 USPQ2d 1279, 1283 (Fed. Cir. 2000). The meaning of every term used in a claim should be apparent from the prior art or from the specification and drawings at the time the application is filed. Claim language may not be ambiguous, vague, incoherent, opaque, or otherwise unclear in describing and defining the claimed invention. MPEP § 2173.05(a). Claim 10 Is Indefinite Because it is Unclear Whether it is Directed to Product or a Method Claim 10 is rejected pursuant to 35 U.S.C. 112, as indefinite because it is unclear whether this claim is directed to the statutory category of method or composition. Claim 10 is reproduced below. Claim 10. The catalyst composition for preparing an ethylene-based polymer of claim 8, wherein the cocatalyst is used in an amount of 0.5 to 10,000 moles based on 1 mole of the metal-ligand complex. The claim 10 preamble recitation of “The catalyst composition . . . of claim 8” indicates the statutory category of composition. However, claim 10 further limits the composition of claim 8 by the recitation of the process step “is used”. A single claim which claims both an apparatus/product and the method steps of using the apparatus/product is indefinite under 35 U.S.C. 112(b). MPEP § 2173.05(p) (citing Ex parte Lyell, 17 USPQ2d 1548 (Bd. Pat. App. & Inter. 1990); In re Katz Interactive Call Processing Patent Litigation, 639 F.3d 1303, 1318, 97 USPQ2d 1737, 1748-49 (Fed. Cir. 2011)). Further, the claimed invention must be to one of the four statutory categories, processes, machines, manufactures and compositions of matter. MPEP § 2106(I). Here it is unclear whether claim 10 is directed to the statutory category of composition of matter or process or both. Claim Rejections - 35 USC § 112(d) The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. § 112(d) Rejection of Claim 10 Claim 10 is rejected under 35 U.S.C. 112(d) as being of improper dependent form for failing to further limit the subject matter of claim 8 upon which it depends, or for failing to include all the limitations of the claim upon which it depends for the following reasons. Claim 10 is reproduced below. Claim 10. The catalyst composition for preparing an ethylene-based polymer of claim 8, wherein the cocatalyst is used in an amount of 0.5 to 10,000 moles based on 1 mole of the metal-ligand complex. The claim 10 preamble recitation of “The catalyst composition . . . of claim 8” indicates the statutory category of composition. However, claim 10 does not recite any language further limiting the composition of claim 8. Claim 10 therefore fails to further limit the subject matter of base claim 8. Subject Matter Free of the Art of Record Claims 1-12 are free of the art of record. The closes art of record is S. Ewart et al., WO 2016/014749 (2016) (“Ewart”) under a § 103 analysis. A prima facie case of obviousness may be made when chemical compounds have very close structural similarities and similar utilities, which entails the motivation of one skilled in the art to make a claimed compound, in the expectation that compounds similar in structure will have similar properties. MPEP § 2144.09(I). The lead compound obviousness analysis requires initial motivation to select a prior art compound and thereafter still further motivation to make the specific structural modifications thereto so as to arrive at a claimed compound. See MPEP § 2143(B) (discussing “lead compound cases” in Examples 9-11 with respect to pharmaceutical applications). However, the MPEP warns against applying the lead compound analysis rigidly in view of the flexible approach stated in KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398, 415-421, 82 USPQ2d 1385, 1395-97 (2007) see also, MPEP § 2143(B), Example 11 (citing Altana Pharma AG v. Teva Pharm. USA, Inc., 566 F.3d 999, 91 USPQ2d 1018 (Fed. Cir. 2009) a ‘restrictive view of the lead compound test would present a rigid test similar to the teaching-suggestion-motivation test that the Supreme Court explicitly rejected in KSR’). Ewart discloses process to form an ethylene-based polymer, said process comprising polymerizing ethylene, and optionally at least one comonomer, in the presence of at least one molecular transition metal complex selected from Formula 1: PNG media_image1.png 200 400 media_image1.png Greyscale where M is titanium, zirconium, or hafnium (which are Group 4 metals), where variables Rx and Ry may be selected from among a listing of alternatives, including halogen, and where Z may be oxygen. Ewart at page 2. Ewart discloses thirty species of Formula 1, none of which comprises a halogen at variables Rx or Ry. Ewart at pages 6-7. The closest species to the instantly claimed compounds disclosed by Ewart is the following compounds b and c. PNG media_image2.png 200 400 media_image2.png Greyscale Ewart at page 6. In order to arrive at a claimed compound, one of ordinary skill must insert a -CF2 group into the carbon chain linking the two oxygen atoms of Ewart compound b; that is one of ordinary skill must assign both of Rx and Ry of Ewart general Formula 1 as F. Here, the claims are not obvious in view of Ewart because this reference does not motivate one of ordinary skill assign both of Rx and Ry of Ewart general Formula 1 as F, for example in Ewart compound species b. Ewart’s teaching that variables Rx or Ry may selected from among a long listing that includes halogen, by itself, and in the absence of any species disclosing a halogen, let alone fluorine at this position, is not sufficient motivation. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALEXANDER R PAGANO whose telephone number is (571)270-3764. The examiner can normally be reached 8:00 AM through 5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. ALEXANDER R. PAGANO Examiner Art Unit 1692 /ALEXANDER R PAGANO/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Feb 08, 2023
Application Filed
Oct 02, 2025
Non-Final Rejection — §112
Apr 14, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600735
METHOD FOR PRODUCING POLYSULPHANE-SILANES BY MEANS OF PHASE TRANSFER CATALYSIS
2y 5m to grant Granted Apr 14, 2026
Patent 12600695
METHOD FOR REACTIVATING A PRECIOUS METAL IRON CATALYST AND PERFORMING A CHEMICAL REACTION
2y 5m to grant Granted Apr 14, 2026
Patent 12600736
METHODS FOR SYNTHESIS OF HIERARCHICALLY ORDERED CRYSTALLINE MICROPOROUS MATERIALS WITH LONG-RANGE MESOPOROUS ORDER
2y 5m to grant Granted Apr 14, 2026
Patent 12595272
METHODS TO PRODUCE ORGANOTIN COMPOSITIONS WITH CONVENIENT LIGAND PROVIDING REACTANTS
2y 5m to grant Granted Apr 07, 2026
Patent 12578335
BIOPROBES FOR LYSYL OXIDASES AND USES THEREOF
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
79%
Grant Probability
83%
With Interview (+4.1%)
2y 1m
Median Time to Grant
Low
PTA Risk
Based on 1049 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month